Amgen Biomarker Toolkit – Biomarker Backgrounder
Personalized Medicine:
In clinical practice, personalized medicine refers to the use of new methods of molecular analysis to better manage a patient’s disease…
News
November 10, 2008
PRINT
PDF
Related Posts
-
Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers -
D-RSC and PSTC presented “Biomarkers for Muscle Diseases” poster at the 2018 MDA Clinical Conference -
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort -
Critical Path Institute Receives Regulatory Support for Liver Injury Biomarker -
What Evidence Do We Need for Biomarker Qualification?